BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ingersgaard MV, Helms Andersen T, Norgaard O, Grabowski D, Olesen K. Reasons for Nonadherence to Statins - A Systematic Review of Reviews. Patient Prefer Adherence 2020;14:675-91. [PMID: 32308373 DOI: 10.2147/PPA.S245365] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Desai NR, Farbaniec M, Karalis DG. Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clin Cardiol 2022. [PMID: 36267039 DOI: 10.1002/clc.23935] [Reference Citation Analysis]
2 Osula D, Wu B, Schesing K, Das SR, Moss E, Alvarez K, Clark C, Halm EA, Brown NJ, Vongpatanasin W. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting. J Am Heart Assoc 2022;11:e027099. [PMID: 36193931 DOI: 10.1161/JAHA.122.027099] [Reference Citation Analysis]
3 Golder S, Weissenbacher D, O’connor K, Hennessy S, Gross R, Hernandez GG. Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media. Drug Saf. [DOI: 10.1007/s40264-022-01212-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Akamine A, Nagasaki Y, Tomizawa A, Arai M, Atsuda K. Risk Factors for Non-Adherence to Medications That Affect Surgery: A Retrospective Study in Japan. PPA 2022;Volume 16:1623-35. [DOI: 10.2147/ppa.s365348] [Reference Citation Analysis]
5 Haller K, Fritzsche S, Kruse I, O’malley G, Ehrenthal JC, Stamm T. Associations Between Personality Functioning, Childhood Trauma and Non-adherence in Cardiovascular Disease: A Psychodynamically-Informed Cross-Sectional Study. Front Psychol 2022;13:913081. [DOI: 10.3389/fpsyg.2022.913081] [Reference Citation Analysis]
6 Wiggins BS, Backes JM, Hilleman D. Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care. Pharmacotherapy 2022;42:428-38. [PMID: 35388918 DOI: 10.1002/phar.2681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Oakley-girvan I, Docherty J. A New Approach to Enhancing Engagement in eHealth Applications (Preprint).. [DOI: 10.2196/preprints.38886] [Reference Citation Analysis]
8 Oakley-girvan I, Docherty J. A New Approach to Enhancing Engagement in eHealth Applications (Preprint). Interactive Journal of Medical Research 2022. [DOI: 10.2196/38886] [Reference Citation Analysis]
9 Stoll F, Eidam A, Michael L, Bauer JM, Haefeli WE. Drug Treatment of Hypercholesterolemia in Older Adults: Focus on Newer Agents. Drugs Aging 2022;39:251-6. [PMID: 35278206 DOI: 10.1007/s40266-022-00928-z] [Reference Citation Analysis]
10 Carvalho BMR, Nascimento LC, Nascimento JC, Gonçalves VSDS, Ziegelmann PK, Tavares DS, Guimarães AG. Citrus Extract as a Perspective for the Control of Dyslipidemia: A Systematic Review With Meta-Analysis From Animal Models to Human Studies. Front Pharmacol 2022;13:822678. [PMID: 35237168 DOI: 10.3389/fphar.2022.822678] [Reference Citation Analysis]
11 Sheldon RJ, Pereira M, Aldersley G, Sales T, Hewitt J, Lyon R, Whale R. Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, subsequent acute care use and effectiveness of medication to which patients switched. Therapeutic Advances in Psychopharmacology 2022;12:204512532110670. [DOI: 10.1177/20451253211067042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tan E, Faller E. Lipid Lowering Effects of Herbal Supplements: A Review. RJPT 2022. [DOI: 10.52711/0974-360x.2022.00044] [Reference Citation Analysis]
13 Christensen RE, Ranpariya V, Kammrath LK, Masicampo E, Roberson KB, Feldman SR. The presence of accountability in digital interventions targeting non-adherence: A review. Patient Education and Counseling 2022. [DOI: 10.1016/j.pec.2022.01.010] [Reference Citation Analysis]
14 Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbuś K, Gąsior M, Jankowski P, Jóźwiak J, Kłosiewicz-Latoszek L, Kowalska I, Małecki M, Prejbisz A, Rakowski M, Rysz J, Solnica B, Sitkiewicz D, Sygitowicz G, Sypniewska G, Tomasik T, Windak A, Zozulińska-Ziółkiewicz D, Cybulska B. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021. Arch Med Sci 2021;17:1447-547. [PMID: 34900032 DOI: 10.5114/aoms/141941] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
15 Osbaugh NA, Billups SJ. A shared decision‐making intervention by pharmacy students to improve statin adherence. J Am Coll Clin Pharm 2022;5:34-41. [DOI: 10.1002/jac5.1575] [Reference Citation Analysis]
16 Grabarek BO, Boroń D, Morawiec E, Michalski P, Palazzo-Michalska V, Pach Ł, Dziuk B, Świder M, Zmarzły N. Crosstalk between Statins and Cancer Prevention and Therapy: An Update. Pharmaceuticals (Basel) 2021;14:1220. [PMID: 34959621 DOI: 10.3390/ph14121220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbuś K, Gąsior M, Jankowski P, Jóźwiak J, Kłosiewicz-latoszek L, Kowalska I, Małecki M, Prejbisz A, Rakowski M, Rysz J, Solnica B, Sitkiewicz D, Sygitowicz G, Sypniewska G, Tomasik T, Windak A, Zozulińska-ziółkiewicz D, Cybulska B. 2021 PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on the diagnosis and therapy of lipid disorders in Poland. diagn lab 2021;57:1-99. [DOI: 10.5604/01.3001.0015.4805] [Reference Citation Analysis]
18 Urina-Jassir M, Pacheco-Paez T, Paez-Canro C, Urina-Triana M. Statin associated adverse reactions in Latin America: a scoping review. BMJ Open 2021;11:e050675. [PMID: 34598987 DOI: 10.1136/bmjopen-2021-050675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tsioufis K, Castellano Vázquez JM, Sykara G, Mondello Malvestiti F, van Vugt J. Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy. Cardiol Ther 2021;10:445-64. [PMID: 34586613 DOI: 10.1007/s40119-021-00240-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bond Z, Scanlon T, Judah G. Systematic Review of RCTs Assessing the Effectiveness of mHealth Interventions to Improve Statin Medication Adherence: Using the Behaviour-Change Technique Taxonomy to Identify the Techniques That Improve Adherence. Healthcare (Basel) 2021;9:1282. [PMID: 34682962 DOI: 10.3390/healthcare9101282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Allen‐tice CJ, Tryon RK, Zierhut HA. Familial Hypercholesterolaemia as a Model for Evaluating the Ethics of Population Testing and Screening for Genetic Disease. eLS 2021. [DOI: 10.1002/9780470015902.a0029236] [Reference Citation Analysis]
22 Kadoglou NPE, Stasinopoulou M. How to Use Statins in Secondary Prevention of Atherosclerotic Diseases: from the Beneficial Early Initiation to the Potentially Unfavorable Discontinuation. Cardiovasc Drugs Ther 2021. [PMID: 34347204 DOI: 10.1007/s10557-021-07233-8] [Reference Citation Analysis]
23 Toth PP. Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines. Am J Prev Cardiol 2021;6:100186. [PMID: 34327506 DOI: 10.1016/j.ajpc.2021.100186] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Vassy JL, Gaziano JM, Green RC, Ferguson RE, Advani S, Miller SJ, Chun S, Hage AK, Seo SJ, Majahalme N, MacMullen L, Zimolzak AJ, Brunette CA. Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial. JAMA Netw Open 2020;3:e2027092. [PMID: 33270123 DOI: 10.1001/jamanetworkopen.2020.27092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
25 Vervloet M, Korevaar JC, Leemrijse CJ, Paget J, Zullig LL, van Dijk L. Interventions to Improve Adherence to Cardiovascular Medication: What About Gender Differences? A Systematic Literature Review. Patient Prefer Adherence 2020;14:2055-70. [PMID: 33154630 DOI: 10.2147/PPA.S260562] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]